Thu, January 6, 2022

Yaron Werber Initiated (ASND) at Hold and Held Target at $136 on, Jan 6th, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. hold-and-held-target-at-136-on-jan-6th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Yaron Werber of Cowen & Co., Initiated "Ascendis Pharma A/S" (ASND) at Hold and Held Target at $136 on, Jan 6th, 2022.

Yaron has made no other calls on ASND in the last 4 months.



There are 4 other peers that have a rating on ASND. Out of the 4 peers that are also analyzing ASND, 1 agrees with Yaron's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Tazeen Ahmad of "B of A Securities" Downgraded from Strong Buy to Hold and Increased Target to $169 on, Wednesday, October 20th, 2021


These are the ratings of the 3 analyists that currently disagree with Yaron


  • Derek Archila of "Wells Fargo" Initiated at Buy and Held Target at $176 on, Wednesday, December 8th, 2021
  • Joseph Schwartz of "SVB Leerink" Maintained at Buy with Increased Target to $190 on, Monday, November 15th, 2021
  • Tiago Fauth of "Credit Suisse" Maintained at Buy with Decreased Target to $179 on, Thursday, November 11th, 2021